BMO Capital Starts Merck (MRK) at Market Perform
Get Alerts MRK Hot Sheet
Rating Summary:
24 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman initiates coverage on Merck (NYSE: MRK) with a Market Perform rating and a price target of $91.00.
The analyst comments "We initiate coverage of Merck & Co with a Market Perform rating a $91 target price, based on our view: 1) Keytruda growth and continued success is fairly valued and priced into the stock; 2) A relatively thin late-stage pipeline (Acceleron was good, but not enough); 3) COVID-19 antiviral may not be as exciting for investors, given recent positive data from Pfizer; 4) Seagen partnership is interesting, but TNBC is rapidly becoming a competitive market."
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $82.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $143 at Truist Securities
- Amazon.com (AMZN) PT Raised to $215 at UBS
- Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
Create E-mail Alert Related Categories
Analyst Comments, New CoverageRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!